08.30.10
Anthony Maida, Ph.D. has joined PharmaNet Development Group as vice president, Clinical Research. Dr. Maida will be responsible for leading PharmaNet's oncology team.
"Anthony's experience spans the drug development process. He has a unique strength in his well balanced expertise across strategic, operational and financial aspects of the business," said Dr. Robert Reekie, chief operating officer and senior executive vice president, Late Stage Development. "We are pleased to have Anthony as part of our outstanding oncology team."
Dr. Maida has more than 20 years of experience providing strategic, operational, and financial expertise to pharmaceutical companies that are focused primarily in the area of oncology. Most recently, he ran his own consulting firm providing both pharmaceutical product development and capital raising capabilities to pharmaceutical firms, working with venture capital funds and investment banks. Prior to joining the pharmaceutical industry, Dr. Maida worked for Lockheed Corporation in a number of key financial roles.
"Anthony's experience spans the drug development process. He has a unique strength in his well balanced expertise across strategic, operational and financial aspects of the business," said Dr. Robert Reekie, chief operating officer and senior executive vice president, Late Stage Development. "We are pleased to have Anthony as part of our outstanding oncology team."
Dr. Maida has more than 20 years of experience providing strategic, operational, and financial expertise to pharmaceutical companies that are focused primarily in the area of oncology. Most recently, he ran his own consulting firm providing both pharmaceutical product development and capital raising capabilities to pharmaceutical firms, working with venture capital funds and investment banks. Prior to joining the pharmaceutical industry, Dr. Maida worked for Lockheed Corporation in a number of key financial roles.
